In a pilot study involving 230 HIV-infected patients, the researchers tested the implementation of privacy-preserving genetic testing, using homomorphic encryption.
The Collaborative African Genomics Network recently finished its second year of grant funding, hitting many of its milestones, and is already digging into the work for their third year.
The test, part of a planned menu expansion, runs on the integrated, automated Roche Cobas 6800 and 8800 platforms.
The funding will support research into epigenomic or ncRNA regulatory mechanisms in HIV/AIDS infection in the context of substance abuse and addiction.
The UCSF-based Blood Systems Research Institute will conduct research using RainDance's digital PCR platforms as part of a new $20 million amfAR Institute for HIV Cure Research.
In PNAS this week: common variants that influence viral load in HIV patients, tumor evolution patterns, and more.
The scientists were able to edit CCR5, the receptor used by HIV to enter cells, without killing the stem cells.
Through a genome-wide association study, an international team of researchers has linked polymorphisms of large effect to host contribution to HIV viral load variation.
The method simplifies previous techniques, and preliminary testing using a microfluidic device indicates it could ultimately be used in low-resource settings.
The scientists fused Cas9 to zinc finger proteins to reduce off-target activity, essentially replacing the other nucleases that had been used with zinc fingers.
The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.
Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.
NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.
In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.